Biomarker testing has become “increasingly critical” in the care of non-small cell lung cancer.A new investigation into testing rates proved “reassuring” to Kenneth L. Kehl, MD, MPH, assistant ...

After China’s 33% year-to-date equity surge in 2025, investors are reminded that emerging market rallies can be fleeting ...

Investor presentations require careful planning and organization. Learn what to consider before presenting an idea to ...

Antivirus software is supposed to keep you safe, but lab tests reveal that many apps collect far more data than you might ...

Discover the differences, advantages, and drawbacks of single-step vs. multiple-step income statements for better financial ...